Cellectar Biosciences CEO James Caruso's 2018 pay falls 23% to $770K
Cellectar Biosciences reports 2018 executive compensation
By ExecPay News
Published: April 29, 2019
Cellectar Biosciences reported fiscal year 2018 executive compensation information on April 29, 2019.
In 2018, five executives at Cellectar Biosciences received on average a compensation package of $415K, a 22% decrease compared to previous year.
Average pay of disclosed executives at Cellectar Biosciences
James V. Caruso, Chief Executive Officer, received $770K in total, which decreased by 23% compared to 2017. 55% of Caruso's compensation, or $425K, was in salary. Caruso also received $205K in bonus and $140K in option awards.
Jarrod Longcor, Chief Business Officer, received a compensation package of $478K, which decreased by 18% compared to previous year. 68% of the compensation package, or $325K, was in salary.
Brian Posner, Chief Financial Officer, earned $417K in 2018.
John E. Friend, Chief Medical Officer, received $399K in 2018, which decreases by 30% compared to 2017.
John P. Hamill, Chief Financial Officer, earned $12K in 2018, a 93% decrease compared to previous year.
Related executives
You may also like
Source: SEC filing on April 29, 2019.